A 4-miRNA signature predicts the therapeutic outcome of glioblastoma

Multimodal therapy of glioblastoma (GBM) reveals inter-individual variability in terms of treatment outcome. Here, we examined whether a miRNA signature can be defined for the a priori identification of patients with particularly poor prognosis. FFPE sections from 36 GBM patients along with overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Niyazi, Maximilian, Pitea, Adriana, Mittelbronn, Michel, Steinbach, Joachim, Sticht, Carsten, Zehentmayr, Franz, Piehlmaier, Daniel, Zitzelsberger, Horst, Ganswindt, Ute, Rödel, Claus, Lauber, Kirsten, Belka, Claus, Unger, Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216759/
https://www.ncbi.nlm.nih.gov/pubmed/27302927
http://dx.doi.org/10.18632/oncotarget.9945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216759/
https://www.ncbi.nlm.nih.gov/pubmed/27302927
http://dx.doi.org/10.18632/oncotarget.9945

Ejemplares similares